Pancreatic cancer mortality in Serbia from 1991-2010-a joinpoint analysis

Croatian Medical Journal

Volumn 54, Issue 4, 2013, Pages 369-375

  Ilić, Milena ^a   Vlajinac, Hristina ^b   Marinković, Jelena ^b   Kocev, Nikola ^b  

^a University of Kragujevac Medical Faculty   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; SERBIA; SEX DIFFERENCE; TREND STUDY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REGRESSION ANALYSIS; SERBIA; SEX DISTRIBUTION;

EID: 84885159646     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2013.54.369     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90. Medline:21296855 doi:10.3322/caac.20107
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917. Medline:21351269 doi:10.1002/ijc.25516
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLO BOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr. Accessed: July 4, 2013.
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. Medline:15761078 doi:10.3322/ canjclin.55.2.74
5. Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1766-73. Medline:16030115 doi:10.1158/1055-9965.EPI-05-0120
6. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al, editors. SEER Cancer Statistics Review, 1975- 2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; Available from: http://seer.cancer.gov/csr/1975_2009_ pops09/. Accessed: July 4, 2013.
7. Qiu D, Katanoda K, Marugame T, Sobue T. A joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Int J Cancer. 2009;124:443-8. Medline:18844218 doi:10.1002/ijc.23911
8. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol. 2010;21:1323-60. Medline:19948741 doi:10.1093/annonc/mdp530
9. World Health Organisation. International classification of diseases, ninth revision (ICD-9). Geneva (Switzerland): World Health Organization; 1977.
10. World Health Organisation. International statistical classification of diseases and related health problems, tenth revision (ICD-10). Geneva (Switzerland): World Health Organization; 1992.
11. The By-law document of emission and form of certificate of death [in Serbian]. Official Gazette SR Serbia 8/2005.
12. Statistical Office of the Republic of Serbia. Demographic yearbook in the Republic of Serbia, 1991-2010. Belgrade: Statistical Office of the Republic of Serbia; 2011.
13. Jensen OM, Parkin DM, Lennan R, Muir CS, Skeet RG. Cancer registration. Principles and methods. Lyon: International Agency for Research on Cancer; 1991.
14. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28:3670-82. Medline:19856324 doi:10.1002/sim.3733
15. Lerman PM. Fitting segmented regression models by grid search. Appl Stat. 1980;29:77-84. doi:10.2307/2346413
16. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-51. Medline:10649300 doi:10.1002/(SICI)1097- 0258(20000215)19:3335::AID-SIM3363.0.CO;2-Z
17. Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004;60:1005-14. Medline:15606421 doi:10.1111/j.0006-341X.2004.00256.x
18. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer. 2004;101:2843-50. Medline:15526321 doi:10.1002/cncr.20666
19. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer. 2004;110:155-69. Medline:15069676 doi:10.1002/ijc.20097
20. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer. 2003;97(12 Suppl):3133-275. Medline:12784323 doi:10.1002/cncr.11380
21. Fernandez E, La Vecchia C, Porta M, Negri E, Lucchini F, Levi F. Trends in pancreatic cancer mortality in Europe, 1955-89. Int J Cancer. 1994;57:786-92. Medline:8206673 doi:10.1002/ ijc.2910570605
22. Wood HE, Gupta S, Kang JY, Quinn MJ, Maxwell JD, Mudan S, et al. Pancreatic cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther. 2006;23:1205-14. Medline:16611282 doi:10.1111/j.1365- 2036.2006.02860.x
23. Yang L, Fujimoto J, Qiu D, Sakamoto N. Trends in cancer mortality in the elderly in Japan, 1970-2007. Ann Oncol. 2010;21:389-96. Medline:19622594 doi:10.1093/annonc/mdp303
24. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al, editors. SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD. Available from: http://seer.cancer. gov/csr/1975_2004. Accessed: July 4, 2013.
25. Vanderveen KA, Chen SL, Yin D, Cress RD, Bold RJ. Benefit of postoperative adjuvant therapy for pancreatic cancer. Cancer. 2009;115:2420-9. Medline:19301434 doi:10.1002/cncr.24269
26. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;393:535-45. Medline:18193270 doi:10.1007/ s00423-007-0266-2
27. Larsson SC, Permert J, Hlkansson N, Nãslund I, Bergkvist L, Wolk A. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer. 2005;93:1310-5. Medline:16288300 doi:10.1038/sj.bjc.6602868
28. Michaud DS, Vrieling A, Jiao L, Mendelsohn JB, Steplowski E, Lynch SM, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control. 2010;21:1213-25. Medline:20373013 doi:10.1007/ s10552-010-9548-z
29. Lowenfels AB, Maisonneuve P. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol. 2004;34:238-44. Medline:15231857 doi:10.1093/jjco/hyh045
30. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 83. Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC 2004. Available from: http://globocan.iarc.fr. Accessed: July 4, 2013.
31. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1994;86:1510-6. Medline:7932805 doi:10.1093/jnci/86.20.1510
32. Potter JD. Pancreas cancer - we know about smoking, but do we know anything else? Am J Epidemiol. 2002;155:793-5. Medline:11978581 doi:10.1093/aje/155.9.793
33. Weiss W, Benarde MA. The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health. 1983;73:1403-4. Medline:6638239 doi:10.2105/AJPH.73.12.1403
34. Weiderpass E, Partanen T, Kaaks R, Vainio H, Porta M, Kauppinen T, et al. Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health. 1998;24:165-74. Medline:9710368 doi:10.5271/sjweh.295
35. Vlajinac H, Adanja B, Jarebinski M. Smoking habits of urban population of Belgrade [in Serbian]. Medicinska istraživanja. 1990;23:73-6.
36. Ministry of Health. Republic of Serbia. National Health Survey, Serbia 2006. Key findings. Belgrade: Ministry of Health, Republic of Serbia; 2007.
37. von Ruesten A, Steffen A, Floegel A, van der A DL, Masala G, Tjonneland A, et al. Trend in obesity prevalence in European adult cohort populations during follow-up since 1996 and their predictions to 2015. PLoS ONE. 2011;6:e27455. Medline:22102897 doi:10.1371/journal.pone.0027455
38. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4- 14. Medline:19896746 doi:10.1016/j.diabres.2009.10.007
39. Vukovic D, Bjegovic V, Vukovic G. Prevalence of chronic diseases according to socioeconomic status measured by wealth index: health survey in Serbia. Croat Med J. 2008;49:832-41. Medline:19090609 doi:10.3325/cmj.2008.49.832
40. B jegovic V, Terzic Z, Marinkovic J, Lalic N, Sipetic S, Laaser U. The burden of type 2 diabetes in Serbia and the cost-effectiveness of its management. Eur J Health Econ. 2007;8:97-103. Medline:17221182 doi:10.1007/s10198-006-0012-7
41. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171-7. Medline:15798840
42. Nagenthiraja K, Ewertz M, Engholm G, Storm HH. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000. Acta Oncol. 2007;46:1064-9. Medline:17952708 doi:10.1080/02841860701381234
43. Wang L, Yang GH, Lu XH, Huang ZJ, Li H. Pancreatic cancer mortality in China (1991-2000). World J Gastroenterol. 2003;9:1819- 23. Medline:12918128
44. Klint A, Engholm G, Storm HH, Tryggvadóttir L, Gislum M, Hakulinen T, et al. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol. 2010;49:578-607. Medline:20491524 doi:10.3109/02841861003739330
45. Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol. 2011;17:867-97. Medline:21412497 doi:10.3748/wjg.v17.i7.867
46. B osetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta P. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 2012;51:3-13. Medline:22162227 doi:10.1002/mc.20785
47. Center for prevention and control of noncommunicable diseases. Cancer incidence and mortality in Central Serbia, 1999-2010. Belgrade: Institute of Public Health of Serbia "Dr. Milan Jovanovic Batut"; 2003-2010.